Mono Pharmacare Profit & Loss Annual

BSE: - | NSE: MONOPHARMA | ISIN: INE0OIP01012 | Sector: -
23.25 -0.75 (-3.13%)Updated : 17 Jun 2025
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 122.3458.4836.9828.27
Total Revenue 122.3458.4836.9828.27
Costof Revenue Total 110.6853.3434.6926.56
Gross Profit 11.665.142.291.71
Selling/ General/ Admin Expenses Total 3.511.100.620.54
Depreciation/ Amortization 0.120.100.110.13
Unusual Expense( Income) 0.000.000.000.00
Other Operating Expenses Total 1.821.070.390.32
Total Operating Expense 116.1355.6135.8127.55
Operating Income 6.212.861.170.72
Interest Inc( Exp) Net- Non- Op Total -2.85-1.22-0.65-0.64
Other Net -0.140.030.030.10
Net Income Before Taxes 3.231.680.550.17
Provisionfor Income Taxes 0.770.440.200.07
Net Income After Taxes 2.461.230.350.10
Minority Interest -0.020.000.000.00
Net Income Before Extra Items 2.441.230.350.10
Net Income 2.441.230.350.10
Total Adjustmentsto Net Income 0.00---
Income Availableto Com Excl Extra Ord 2.441.230.350.10
Income Availableto Com Incl Extra Ord 2.441.230.350.10
Diluted Net Income 2.441.230.350.10
Diluted Weighted Average Shares 1.541.771.771.77
Diluted EPS Excluding Extra Ord Items 1.590.700.200.05
Diluted Normalized EPS 1.590.700.200.05
period Length 12.0012.0012.0012.00
period Type ----
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,716.60+22.50(1.33%)
1,640.15+16.40(1.01%)
2,264.50+20.85(0.93%)
675.00-11.70 (-1.70%)